194 related articles for article (PubMed ID: 26986252)
1. Hexokinase 2 is a determinant of neuroblastoma metastasis.
Botzer LE; Maman S; Sagi-Assif O; Meshel T; Nevo I; Yron I; Witz IP
Br J Cancer; 2016 Mar; 114(7):759-66. PubMed ID: 26986252
[TBL] [Abstract][Full Text] [Related]
2. Lung-residing metastatic and dormant neuroblastoma cells.
Edry Botzer L; Maman S; Sagi-Assif O; Meshel T; Nevo I; Bäuerle T; Yron I; Witz IP
Am J Pathol; 2011 Jul; 179(1):524-36. PubMed ID: 21703429
[TBL] [Abstract][Full Text] [Related]
3. Generation and characterization of novel local and metastatic human neuroblastoma variants.
Nevo I; Sagi-Assif O; Edry Botzer L; Amar D; Maman S; Kariv N; Leider-Trejo LE; Savelyeva L; Schwab M; Yron I; Witz IP
Neoplasia; 2008 Aug; 10(8):816-27. PubMed ID: 18683320
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of Lung Carcinoma A549 Cell Growth by Knockdown of Hexokinase 2 In Situ and In Vivo.
Xi F; Ye J
Oncol Res; 2016 Jan; 23(1-2):53-9. PubMed ID: 26802651
[TBL] [Abstract][Full Text] [Related]
5. Significances of contactin-1 expression in human gastric cancer and knockdown of contactin-1 expression inhibits invasion and metastasis of MKN45 gastric cancer cells.
Chen DH; Yu JW; Wu JG; Wang SL; Jiang BJ
J Cancer Res Clin Oncol; 2015 Dec; 141(12):2109-20. PubMed ID: 25952582
[TBL] [Abstract][Full Text] [Related]
6. Licochalcone A suppresses hexokinase 2-mediated tumor glycolysis in gastric cancer via downregulation of the Akt signaling pathway.
Wu J; Zhang X; Wang Y; Sun Q; Chen M; Liu S; Zou X
Oncol Rep; 2018 Mar; 39(3):1181-1190. PubMed ID: 29286170
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-708-5p acts as a therapeutic agent against metastatic lung cancer.
Wu X; Liu T; Fang O; Dong W; Zhang F; Leach L; Hu X; Luo Z
Oncotarget; 2016 Jan; 7(3):2417-32. PubMed ID: 26678031
[TBL] [Abstract][Full Text] [Related]
8. Cell adhesion molecules in metastatic neuroblastoma models.
Schwankhaus N; Gathmann C; Wicklein D; Riecken K; Schumacher U; Valentiner U
Clin Exp Metastasis; 2014 Apr; 31(4):483-96. PubMed ID: 24549749
[TBL] [Abstract][Full Text] [Related]
9. Developmental profile and regulation of the glycolytic enzyme hexokinase 2 in normal brain and glioblastoma multiforme.
Wolf A; Agnihotri S; Munoz D; Guha A
Neurobiol Dis; 2011 Oct; 44(1):84-91. PubMed ID: 21726646
[TBL] [Abstract][Full Text] [Related]
10. XBP1 silencing decreases glioma cell viability and glycolysis possibly by inhibiting HK2 expression.
Liu Y; Hou X; Liu M; Yang Z; Bi Y; Zou H; Wu J; Che H; Li C; Wang X; Wang K; Zhong C; Zhang J; Yu T; Bian Q; Chai S; Liu H; Ai J; Zhao S
J Neurooncol; 2016 Feb; 126(3):455-62. PubMed ID: 26680227
[TBL] [Abstract][Full Text] [Related]
11. Identification of an aptamer through whole cell-SELEX for targeting high metastatic liver cancers.
Rong Y; Chen H; Zhou XF; Yin CQ; Wang BC; Peng CW; Liu SP; Wang FB
Oncotarget; 2016 Feb; 7(7):8282-94. PubMed ID: 26882565
[TBL] [Abstract][Full Text] [Related]
12. Benserazide, a dopadecarboxylase inhibitor, suppresses tumor growth by targeting hexokinase 2.
Li W; Zheng M; Wu S; Gao S; Yang M; Li Z; Min Q; Sun W; Chen L; Xiang G; Li H
J Exp Clin Cancer Res; 2017 Apr; 36(1):58. PubMed ID: 28427443
[TBL] [Abstract][Full Text] [Related]
13. VEGF-C mediates RhoGDI2-induced gastric cancer cell metastasis and cisplatin resistance.
Cho HJ; Kim IK; Park SM; Baek KE; Nam IK; Park SH; Ryu KJ; Choi J; Ryu J; Hong SC; Jeong SH; Lee YJ; Ko GH; Kim J; Won Lee C; Soo Kang S; Yoo J
Int J Cancer; 2014 Oct; 135(7):1553-63. PubMed ID: 24585459
[TBL] [Abstract][Full Text] [Related]
14. Neuroblastoma patient-derived orthotopic xenografts retain metastatic patterns and geno- and phenotypes of patient tumours.
Braekeveldt N; Wigerup C; Gisselsson D; Mohlin S; Merselius M; Beckman S; Jonson T; Börjesson A; Backman T; Tadeo I; Berbegall AP; Ora I; Navarro S; Noguera R; Påhlman S; Bexell D
Int J Cancer; 2015 Mar; 136(5):E252-61. PubMed ID: 25220031
[TBL] [Abstract][Full Text] [Related]
15. A Tumor Agnostic Therapeutic Strategy for Hexokinase 1-Null/Hexokinase 2-Positive Cancers.
Xu S; Herschman HR
Cancer Res; 2019 Dec; 79(23):5907-5914. PubMed ID: 31434645
[TBL] [Abstract][Full Text] [Related]
16. Hypoxia-inducible hexokinase-2 enhances anti-apoptotic function via activating autophagy in multiple myeloma.
Ikeda S; Abe F; Matsuda Y; Kitadate A; Takahashi N; Tagawa H
Cancer Sci; 2020 Nov; 111(11):4088-4101. PubMed ID: 32790954
[TBL] [Abstract][Full Text] [Related]
17. Regulation of the epithelial to mesenchymal transition and metastasis by Raf kinase inhibitory protein-dependent Notch1 activity.
Noh HS; Hah YS; Ha JH; Kang MY; Zada S; Rha SY; Kang SS; Kim HJ; Park JY; Byun JH; Hahm JR; Shin JK; Jeong SH; Lee YJ; Kim DR
Oncotarget; 2016 Jan; 7(4):4632-46. PubMed ID: 26716415
[TBL] [Abstract][Full Text] [Related]
18. [Expression of hexokinase-II gene in human colon cancer cells and the therapeutic significance of inhibition thereof].
Peng QP; Liang HJ; Zhou Q; Zhou JM; Fu XL; Zhong DP
Zhonghua Yi Xue Za Zhi; 2007 Apr; 87(15):1058-62. PubMed ID: 17672972
[TBL] [Abstract][Full Text] [Related]
19. [miR-181c inhibits glycolysis by targeting hexokinase 2 in cancer-associated fibroblasts].
Lan H; Luo L; Qi X; Gong Y; Chen Y
Nan Fang Yi Ke Da Xue Xue Bao; 2015 Nov; 35(11):1619-23. PubMed ID: 26607087
[TBL] [Abstract][Full Text] [Related]
20. Lectin PCL inhibits the Warburg effect of PC3 cells by combining with EGFR and inhibiting HK2.
Zhang H; Du X; Sun TT; Wang CL; Li Y; Wu SZ
Oncol Rep; 2017 Mar; 37(3):1765-1771. PubMed ID: 28098871
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
